These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5686580)

  • 1. Estimation of uricosuric activity of sulfinpyrazone in healthy adults.
    Malamos B; Sfikakis P; Tsekos G; Tasiopoulos T
    Z Rheumaforsch; 1968 Apr; 27(3):125-8. PubMed ID: 5686580
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of ethambutol-induced hyperuricemia.
    Postlethwaite AE; Kelley WN
    Arthritis Rheum; 1972; 15(4):403-9. PubMed ID: 5046470
    [No Abstract]   [Full Text] [Related]  

  • 3. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

  • 4. Uricosuric effect of glyceryl guaiacolate.
    Ramsdell CM; Postlethwaite AE; Kelley WN
    J Rheumatol; 1974 Mar; 1(1):114-6. PubMed ID: 4617771
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic effects of nicotinic acid on human purine metabolism.
    Gershon SL; Fox IH
    J Lab Clin Med; 1974 Aug; 84(2):179-86. PubMed ID: 4367231
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML
    N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the influence of Anturan on ric acid and plasma lipids in patients with gout].
    Günther R; Herbst M; Knapp E; Siller K
    Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations with Rabenid in patients with locomotor disease.
    Konrád K
    Ther Hung; 1989; 37(2):99-102. PubMed ID: 2686087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the hypouricemic effects of calcitonin and sulfinpyrazone].
    Rico Lenza H; Huertas García-Alejo R; del Río Vázquez A; Espinós Pérez D
    Rev Clin Esp; 1982 Feb; 164(4):249-52. PubMed ID: 6283606
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites.
    Schlosstein LH; Kippen I; Whitehouse MW; Bluestone R; Paulus HE; Klinenberg JR
    J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with a new uricolytic agent].
    Alessandri C; Violi F; Bonavita MS
    Recenti Prog Med; 1986 Mar; 77(3):147-8. PubMed ID: 3715181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary uric acid excretion in patients with gout].
    Eyman E; Sopata I
    Reumatologia; 1972; 10(3):197-204. PubMed ID: 4634598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
    Barcelo P; Santamaria A
    Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652
    [No Abstract]   [Full Text] [Related]  

  • 15. Uric acid excretion in the relatives of patients with gout.
    Scott JT; Pollard AC
    Ann Rheum Dis; 1970 Jul; 29(4):397-400. PubMed ID: 4916770
    [No Abstract]   [Full Text] [Related]  

  • 16. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout.
    Moriwaki Y; Yamamoto T; Takahashi S; Yamakita J; Tsutsumi Z; Hada T
    J Rheumatol; 2001 Jun; 28(6):1306-10. PubMed ID: 11409124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies.
    Ferraccioli G; Spisni A; Ambanelli U
    J Rheumatol; 1984 Jun; 11(3):330-2. PubMed ID: 6547486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ribomononucleotides given orally on uric acid production in man.
    Gutman AB; Yü TF
    Adv Exp Med Biol; 1974; 41():401-5. PubMed ID: 4832563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperuricemia and gout; treatment of an acute attack of gout].
    Gast LF; Cats A; van Romunde LK
    Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.